Inhibition of Epidermal Growth Factor Receptor-associated Tyrosine Kinase Blocks Glioblastoma Invasion of the Brain
- 1 January 1997
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 40 (1) , 141-151
- https://doi.org/10.1097/00006123-199701000-00032
Abstract
Glioblastoma multiforme is a malignant primary brain tumor associated with short patient survival despite aggressive treatment, in part because of its propensity to aggressively infiltrate into brain tissue. Glioblastoma multiforme is also unique because it is the only nonepithelial human tumor for which excessive activation of epidermal growth factor receptor (EGFR) has been consistently linked to tumor growth and patient survival, and EGFR activation promotes glioblastoma multiforme infiltration in vitro. Cocultures of human glioblastoma spheroids (derived from three separate patients) and fetal rat brain aggregates were examined for infiltration using confocal microscopy, in the presence of 0 to 100 mumol/L genistein, a tyrosine kinase (TK) inhibitor, and 3 mumol/L tyrphostin A25, a specific EGFR-TK inhibitor. Infiltration (not attachment) was completely inhibited by genistein at 10 mumol/L, the IC20 for monolayer growth inhibition in two cell lines. Tyrphostin A25 at 3 mumol/L (the IC20 for monolayers) reduced invasion in a third cell line from 38.8 +/- 6.1% invasion-hour per hour (n = 5) to 2.9 +/- 1.2% invasion-hour per hour (n = 6) (P = 0.0002, two-tailed t test, 93% inhibition), and from 0.54 +/- 0.065% per hour (slope) to 0.028 +/- 0.018% per hour (P = 0.00001, 95% inhibition). Maximal percent invasion was reduced from 100 +/- 0 to 7.4 +/- 5.6% of the fetal rat brain aggregate. No change was detected in EGFR-associated tyrosine phosphorylation at those doses in monolayers by 32P immunolabeling, consistent with the known effects of low concentrations of TK inhibitors. An increase in expression of wild-type and truncated EGFR was demonstrated by Western blotting. Invasion was equally well inhibited by a monoclonal antibody to the high-affinity ligand binding domain of EGFR and not by antibody to an inactive domain. Our observations support the role of EGFR activation as a determinant by which glioblastoma invades normal brain tissue, and we show that invasion can be effectively inhibited at much lower concentrations of TK inhibitors than are necessary for growth suppression.Keywords
This publication has 69 references indexed in Scilit:
- Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma cell linesEuropean Journal Of Cancer, 1995
- Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement.The Journal of cell biology, 1994
- Amplification of the epidermal‐growth‐factor‐receptor gene correlates with different growth behaviour in human glioblastomaInternational Journal of Cancer, 1994
- How receptor tyrosine kinases activate rasTrends in Biochemical Sciences, 1993
- Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs)Journal of Neuro-Oncology, 1993
- EGF receptor amplification and expression in human brain tumoursEuropean Journal Of Cancer, 1992
- Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance geneBiochemical and Biophysical Research Communications, 1991
- Transforming growth factor-α, epidermal growth factor receptor, and proliferating potential in benign and malignant gliomasJournal of Neurosurgery, 1991
- Involvement of protein kinase C in the mitogenic and chemotaxis effects of basic fibroblast growth factor on bovine cerebral cortex capillary endothelial cellsFEBS Letters, 1990
- Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cellsJournal of Neuroscience Research, 1982